How TENS Affects Pain, Medication Use, and Muscle Function in Older Adults With Hip Fractures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversity of the Sinos Valley

About this trial

The goal of this clinical trial is to learn if transcutaneous electrical nerve stimulation (TENS) can reduce perioperative pain in older adults with hip fractures. It will also evaluate its effects on physiological and psychological outcomes. The main questions it aims to answer are:

Does adding TENS to usual care during the preoperative phase reduce pain intensity and analgesic consumption? Does TENS affect pressure pain threshold and vital signs (blood pressure, heart rate, and respiratory rate)?

Researchers will compare active TENS to sham TENS (no perceptible stimulation) to see if TENS is effective in reducing pain and improving related outcomes.

Participants will:

* Undergo a standardized baseline assessment, including evaluation of pain, vital signs, anxiety, discomfort, and pressure pain threshold * Complete questionnaires assessing quality of life, physical activity, depressive symptoms, anxiety, fear of falling, and pain catastrophizing * Be randomly assigned to receive either active TENS or sham TENS * Receive a single 45-minute TENS session * Have their analgesic use recorded for the 24 hours before and after the intervention.

Eligibility criteria

Qualifiers

Older adults (male and female) diagnosed with hip fracture

Age ≥ 60 years

Admitted to the hospital inpatient unit (HPS)

Mini-Mental State Examination (MMSE) score ≥ 20

Disqualifiers

Conditions contraindicating electrical stimulation, such as presence of a pacemaker, significant sensory loss in the lower limbs, or skin lesions at the electrode placement site

History of neurological or cognitive impairment that may interfere with understanding of the assessments

Previous treatment with neuromuscular electrical stimulation (NMES) in the lower limb within the last 3 months

Trial design

Treatments tested in this trial

  • Active Transcutaneous Electrical Nerve Stimulation (TENS)
  • Sham Transcutaneous Electrical Nerve Stimulation (Sham TENS)

Treatment groups

32 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators